Brief: Tracon Pharmaceuticals Increases Previously Announced Bought Deal Offering Of Common Stock To $15 Mln
22/07/2021 03:32
July 21 (Reuters) - TRACON Pharmaceuticals Inc TCON.O :
* TRACON PHARMACEUTICALS INCREASES PREVIOUSLY ANNOUNCED
BOUGHT
DEAL OFFERING OF COMMON STOCK TO $15.0 MILLION
* TRACON PHARMACEUTICALS-INCREASED SIZE OF PREVIOUSLY
ANNOUNCED
PUBLIC OFFERING,PURCHASE ON FIRM COMMITMENT BASIS 3,926,702
SHARES OF PRICE $3.82PER SHARE
Source text for Eikon: ID:nGNX7LSTW2
Further company coverage: TCON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants